-
Uncategorized2 months agoNew rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies
After a courtroom defeat, Trump administration health officials have revised the governing documents for a key federal vaccine panel to broaden its membership, increase its focus...
-
Uncategorized2 months agoInvivyd reveals plans to test an antibody drug against measles
The drug, which Invivyd sees as a potential treatment and “targeted alternative” for the vaccine-hesitant, comes as measles cases in the U.S. are reaching levels not...
-
Uncategorized2 months ago
FDA plans another safety study of abortion drug after court order
The FDA is again looking into the safety of the abortion drug mifepristone following a Louisiana court order and calls from Republican lawmakers to investigate the...
-
Uncategorized2 months ago
AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuit
AbbVie filed suit against the federal government on Wednesday over its interpretation of the word “patient” under the 340B federal drug discount program. The lawsuit is...
-
Uncategorized2 months ago
Labguru Customer Portal Launched for CRO/CDMO and Client Collaboration
Officials at Cenevo say the company has launched the Labguru Customer Portal to help streamline client communication for CROs, CDMOs, and others. CROs and CDMOs operate...
-
Uncategorized2 months agoChasing a tough-to-treat lung disease, Avalyn plans an IPO
Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior versions of entrenched — but flawed — medicines for...
-
Uncategorized2 months agoSTAT+: A new health care blueprint from a key Democratic think tank
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized2 months ago
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
-
Uncategorized2 months ago
Everyone has a mental health chatbot. Now what?
Everyone has a mental health chatbot. Now what?
-
Uncategorized2 months agoSTAT+: FDA rejects an industry proposal to deregulate some AI devices
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
